Skip to main content
logo
Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
1.515
-0.125 (-7.62%)
Aug 20, 2026, 4:00 PM EDT - Market closed

Neumora Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-212.75-236.93-243.79-235.93-130.9-237.31
Depreciation & Amortization
0.050.210.630.670.590.54
Other Amortization
1.721.21----
Loss (Gain) From Sale of Assets
0.130.64----
Asset Writedown & Restructuring Costs
---63.913157
Loss (Gain) From Sale of Investments
-0.75-2.93-5.72-3.74-0.71-
Stock-Based Compensation
27.9829.8839.9917.248.34.27
Other Operating Activities
0.271.923.313.481.771.04
Change in Accounts Payable
3.50.072.87-0.58-1.25-0.76
Change in Other Net Operating Assets
-0.67-0.5119.76-8.32-5.7-0.2
Operating Cash Flow
-180.52-206.44-182.94-163.28-114.9-75.42
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
---0.78-4.71-13.51-0.82
Sale of Property, Plant & Equipment
0.210.22----
Investment in Securities
93.83168.3-69.7869.09-154.5-
Investing Cash Flow
94.03168.52-70.5664.39-168.01-0.82

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-57.16----
Net Debt Issued (Repaid)
38.7657.16----
Issuance of Common Stock
40.4819.9321.6236.232.663.47
Repurchase of Common Stock
----0.49--
Other Financing Activities
-0.45---3.8-0.92-1.21
Financing Cash Flow
78.877.0921.6231.94115.74293.51

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-7.6939.17-231.89133.05-167.17217.27

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-180.52-206.44-183.71-167.99-128.41-76.24
Free Cash Flow Growth
------
Free Cash Flow Per Share
-1.04-1.26-1.15-2.58-4.72-3.48
Levered Free Cash Flow
-99.42-115.71-100.7-111.24-93.02-37.08
Unlevered Free Cash Flow
-97.1-114.91-100.7-111.24-93.02-37.08

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
2.831.5----
Cash Income Tax Paid
0.350.320.47---
Change in Working Capital
2.84-0.4422.64-8.9-6.95-0.96
SEC Filings: 10-K · 10-Q